Adverse effects of marijuana;Effets somatiques liés à la consommation de cannabis

Revue du Praticien

Volumn 55, Issue 1, 2005, Pages 41-49

  Mallaret, Michel ^b   Dal'Bo Rohrer, Dominique ^b   Demattéis, Maurice ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CARCINOGEN; DRONABINOL;

AMNESIA; ARTERITIS; CANNABIS ADDICTION; CHRONIC BRONCHITIS; DRIVING ABILITY; EMERGENCY WARD; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INTOXICATION; NONHUMAN; ORTHOSTATIC HYPOTENSION; RESPIRATORY SYSTEM; REVIEW; SMOKING; SYNCOPE; VASOSPASM;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AUTOMOBILE DRIVING; CANNABIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVALS; EMERGENCIES; FEMALE; HEALTH EDUCATION; HUMANS; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; ODDS RATIO; RISK; RISK FACTORS; SMOKING;

EID: 13144253150     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Gupta BD, Jani CB, Shah PF. Fatal "Bhang" poisoning. Med Sci Law 2001; 41: 349-52.
2. Fant RV, Heishman SJ, Bunker EB, Pickworth WB. Acute and residual effects of marijuana in humans. Pharmacol Biochem Behav 1998; 60: 777-84.
3. Wright A, Terry P. Modulation of the effects of alcohol on driving-related psychomotor skills by chronic exposure to cannabis. Psychopharmacology 2001; 160: 213-9.
4. Inserm. Expertise collective. Cannabis. Quels effets sur le comportement et la santé ? Paris: Inserm, 2001.
5. Bro P, Schou J, Topp G. Cannabis poisoning with analytical verification. N Engl J Med 1975; 293: 1049-50.
6. Macnab A, Anderson E, Susak L. Ingestion of cannabis: a cause of coma in children. Pediatr Emerg Care 1989; 5: 238-9.
7. Weiss JL, Watanabe AH, Lemberger L et al. Cardiovascular effects of delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther 1972; 13: 671-84.
8. Mathew RJ, Wilson WH, Davis R. Postural syncope after marijuana : a transcranial doppler study of the hemodynamics. Pharmacol Biochem Behav 2003; 75: 309-18.
9. Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med 2003; 42: 365-9.
10. Wu TC, Tashkin DP, Djahed B et al. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988; 318: 347-51.
11. Disdier P, Granel B, Serratrice J et al. Cannabis arteritis revisited: ten new case reports. Angiology 2001; 52: 1-5.
12. Groger A, Aslani A, Wolter T, Noah EM, Pallua N. A rare case of cannabis arteritis. Vasa 2003; 32: 95-7.
13. Aronow WS, Cassidy J. Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther 1975; 17: 549-54.
14. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001; 103: 2805-9.
15. Servoss SJ, Januzzi JL, Muller JE. Triggers of acute coronary syndromes. Prog Cardiovasc Dis 2002; 44: 369-80.
16. Geller T, Loftis L, Brink DS. Cerebellar infarction in adolescent males associated with acute marijuana use. Pediatrics 2004; 113: 365-70.
17. Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral D9-tetrahydrocannabinol in healthy young men. N Engl J Med 1973; 288: 985-9.
18. Tashkin DP, Shapiro BJ, Frank IM. Acute effects of smoked marijuana and oral D9-tetrahydrocannabinol on specific airway conductance in subjects with asthma. Am Rev Respir Dis 1974; 109: 420-8.
19. Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents "freebasing" among habitual users of marijuana with or without tobacco. Opin Pulm Med 2001; 7: 43-61.
20. Taylor DR, Poulton R, Moffitt TE et al. The respiratory effects of cannabis in young adults. Addiction 2000; 95: 1669-77.
21. Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD. Respiratory effects of non-tobacco cigarettes. BMJ 1987; 295: 1516-8.
22. Gong H Jr, Fligiel S, Tashkin DP et al. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis 1987; 136: 142-9.
23. Fligiel SEG, Roth MD, Kleerup EC et al. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana or tobacco. Chest 1997; 112: 319-26.
24. Feldman AL, Sullivan JT, Passero MA et al. Pneumothorax in polysubstance abusing marijuana and tobacco smokers: 3 cases. J Subst Abuse 1993; 5: 183-6.
25. Miller WE, Spiekerman RE, Hepper NC. Pneumomediastinum resulting from performing valsalva manaeuver during marijuana smoking. Chest 1972; 62: 233-4.
26. Tashkin DP, Coulson AH, Clark VA et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and non-smokers. Am Rev Respir Dis 1987; 135: 209-16.
27. Tashkin DP, Simmons M, Sherrill D et al. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age : a longitudinal study. Am J Respir Crit Care Med Dis 1997; 155: 141-8.
28. Kagen SL, Kurup VP, Sohnle PC et al. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 1983; 71: 389-93.
29. Cottrell JC, Sohn SS, Vogel WH. Toxic effects of marihuana tar on mouse skin. Arch Environ Health 1973; 26: 277-8.
30. Matthias P, Tashkin DP, Marques-Maqallanes JA et al. Effects of varying marijuana potency on deposition of tar and δ9-THC in the lung during smoking. Pharmacol Biochem Behavior 1997; 58: 1145-50.
31. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996; 274: 430-2.
32. Zimmerman AM, Stich H, San R. Nonmutagenic action of cannabinoids in vitro. Pharmacology 1998; 16: 333-43.
33. Chan PC, Sills RC, Braun AG, Haseman JK, Bucher JR. Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fundam App Toxicol 1996; 30: 109-17.
34. Wehner FC, Van Rensburg SJ, Thiel PG. Mutagenicity of marijuana and Transkei tobacco smoke condensates in the Salmonella/microsome assay. Mutat Res 1980; 77: 135-42.
35. Busch FW, Seid DA, Wei ET. Mutagenic activity of marihuana smoke condensates. Cancer 1979; 6: 319-24.
36. Novotny M, Lee ML, Bartle KD. A possible chemical basis for the higher mutagenicity of marijuana smoke as compared to tobacco smoke. Experientia 1976; 32: 280-2.
37. Barsky SH, Roth MD, Kleerup EC et al. Similar molecular alterations in bronchial epithelium are observed in habitual smokers of marijuana, cocaine or tobacco. J Nat Can Inst 1998; 90: 1198-204.
38. Donald PJ. Marijuana smoking - possible cause of head and neck carcinome in young patients. Otolaryngol Head Neck Surg 1986; 94: 517-21.
39. Fung M, Gallagher C, Machtay M. Lung and aero-digestive cancers in young marijuana smokers. Tumori 1999; 85: 140-2.
40. Sridhar KS, Raub WA, Weatherby NL et al. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs 1994; 26: 285-8.
41. Zhang ZF, Morgenstern H, Spitz MR et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999; 9: 1043-9.
42. Hsairi M, Achour N, Zouari B et al. Etiologic factors in primary branchial carcinome in Tunisia. Tunis Med 1993; 71: 265-8.
43. Smith MS, Yamamoto Y, Newton C et al. Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila. Proc Soc Exp Biol Med 1997; 214: 69-75.
44. Abrams DI, Hilton JF, Leiser RJ et al. Short-term effects of cannabinoids in patients with HIV-1 infection : a randomized, placebo-controlled clinical trial. Ann Intern Med 2003; 139: 258-66.
45. Clough AR, Wang Z, Bailie RS, Burns CB, Currie BJ. Case-control study of the association between kava use and pneumonia in eastern Arnhem and Aboriginal communities (Northern Territory, Australia). Epidemiol Infect 2003; 131: 627-35.
46. Harmon J, Haliapoulos MA. Gynecomastia in marihuana users. N Engl J Med 1972; 287: 936.
47. Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 1974; 290: 872-4.
48. Vescovi PP, Pedrazzoni M, Michelini M et al. Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol Depend 1992; 23: 59-63.
49. Mendelson JH, Ellingboe J, Kuehnle JC, Mello NK. Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J Pharmacol Exp Ther 1978; 207: 611-7.
50. Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol Biochem Behav 1986; 24: 1749-54.
51. Halikas JA, Weller RA, Morse C. Effects of regular marijuana use on sexual performance. J Psychoactive Drugs 1982; 14 (Suppl. 2):59-70.